[Efficacy and safety of bendamustine combined with pomalidomide and dexamethasone in patients with relapsed and refractory multiple myeloma].

Wang, J; Yao, Y; Shang, J J; Ma, X; Fu, C C; Wu, D P; Jin, S

Wang, J; Yao, Y; Shang, J J; Ma, X; Fu, C C; Wu, D P; Jin, S.

Afiliação

Wang J; Department of Hematology, Soochow Hopes Hematology Hospital, Suzhou 215128, China.
Yao Y; Department of Hematology, Soochow Hopes Hematology Hospital, Suzhou 215128, China.
Shang JJ; Department of Hematology, the First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou 215006, China.
Ma X; Department of Hematology, the First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou 215006, China.
Fu CC; Department of Hematology, the First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou 215006, China.
Wu DP; Department of Hematology, the First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou 215006, China.
Jin S; Department of Hematology, the First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou 215006, China.

Zhonghua Xue Ye Xue Za Zhi ; 44(6): 504-507, 2023 Jun 14.

Article em Zh | MEDLINE | ID: mdl-37550209

Assuntos

Mieloma Múltiplo; Humanos; Mieloma Múltiplo/tratamento farmacológico; Cloridrato de Bendamustina/uso terapêutico; Recidiva Local de Neoplasia/tratamento farmacológico; Dexametasona/uso terapêutico; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Humans Idioma: Zh Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google